Weirong Chen

USPTO Granted Patents = 8 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 25(Granted Patents)

Location History:

Iselin, NJ (US) (2002)
Waltham, MA (US) (2007 - 2019)
Cambridge, MA (US) (2021)

Company Filing History:

3 out of 850

Millennium Pharmaceuticals Limited

patents

3 out of 63

Sunesis Pharmaceuticals, Inc.

Knopp Biosciences, LLC

where one patent can have more than one assignee

Years Active: 2002-2021

Loading Chart...

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11192856 - Process for preparing alpha-carboxamide pyrrolidine derivatives (2021-12-07),

2. 10208003 - Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds (2019-02-19),

3. 9920048 - Substituted pyrimidines for inhibiting Raf kinase activity (2018-03-20),

4. 9556177 - Substituted 1,3-thiazoles as synthetic intermediates for preparation of Raf kinase inhibitors (2017-01-31),

5. 9512096 - Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds (2016-12-06),

6. 8293752 - Compounds useful as Raf kinase inhibitors (2012-10-23),

7. 7199142 - 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists (2007-04-03),

8. 6495713 - Synthesis of ketosulfone esters (2002-12-17),

Title: Weirong Chen: Innovator in Pharmaceutical Chemistry

Introduction

Weirong Chen is a notable inventor based in Waltham, MA (US), recognized for his contributions to pharmaceutical chemistry. With a total of 8 patents, Chen has made significant advancements in the synthesis of various chemical compounds.

Latest Patents

Among his latest patents, Chen has developed a process for preparing alpha-carboxamide pyrrolidine derivatives. This invention focuses on a novel method for synthesizing (2S, 5R)-5-(4-((2-fluorobenzyl)oxy)phenyl)pyrrolidine-2-carboxamide, along with novel intermediates essential for this process. Another significant patent involves the synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds. This invention presents an improved process for creating amino-substituted compounds, including 2-amino-4,5,6,7-tetrahydro-6-(n-propylamino)benzothiazole, and details the methods and intermediates associated with this synthetic process.

Career Highlights

Weirong Chen has worked with prominent companies in the pharmaceutical industry, including Millennium Pharmaceuticals Limited and Sunesis Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in drug development and chemical synthesis.

Collaborations

Throughout his career, Chen has collaborated with esteemed colleagues such as William F Kiesman and Erwin Irdam. These partnerships have likely enhanced his research and innovation capabilities.

Conclusion

Weirong Chen's work in pharmaceutical chemistry exemplifies the impact of innovative thinking in the field. His patents and collaborations reflect a commitment to advancing chemical synthesis and drug development.

This text is generated by artificial intelligence and may not be accurate.